Sosei Collaborates With GSK On Immune Disorders Of Digestive System; Eligible To Receive Up $481 Mln
(RTTNews) - Japan's Sosei Group Corp said that it has reached a global collaboration and license agreement with GlaxoSmithKline Plc (GSK.L, GSK) targeting immune disorders of the digestive system in a ...
GSK and Genomics plc will collaborate on a new precision medicine initiative that assesses how genetic data can be used in clinical trial design, Genomics announced April 30. The project will look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results